Loading people...
James Weis is a venture capitalist, computational biologist, and the Partner and CEO at Nest Bio Labs and Hatch Bio Labs in Cambridge, Massachusetts. He holds a doctorate in Computational and Systems Biology from the Massachusetts Institute of Technology, where he conducted research at the MIT Media Lab, alongside an undergraduate degree from Brown University. Weis originally founded and served as President of the MIT Biotechnology Group from 2014 to 2017, and he subsequently co-founded the MIT Alumni Life Sciences Angel Group in 2016. Currently overseeing a team of fifteen employees, he has authored peer-reviewed publications on applying machine learning to biological engineering and molecular design in scientific journals like Nature Biotechnology. His professional focus centers on leveraging artificial intelligence and computational biology to identify, incubate, and invest in early-stage biotechnology, life sciences, and healthcare companies.
James Weis stands as a distinguished Partner at Nest.Bio Labs, a prominent organization dedicated to fostering innovation within the biotechnology and life sciences sectors. In his crucial role, James is instrumental in identifying, evaluating, and supporting groundbreaking ventures that promise to reshape the future of healthcare and scientific discovery. His strategic insights and deep industry knowledge are vital in guiding early-stage companies through critical development phases, from initial concept to market readiness.
At Nest.Bio Labs, James Weis's investment focus is sharply honed on disruptive technologies and novel therapeutic platforms. He actively seeks out opportunities in areas such as advanced therapeutics, precision medicine, diagnostics, medical devices, and digital health solutions. With a keen eye for scientific merit and market potential, James is committed to backing companies that address significant unmet medical needs and possess the potential for scalable impact. His portfolio strategy emphasizes long-term growth and the translation of cutting-edge research into tangible patient benefits.
James Weis brings a wealth of experience and a robust background to his position at Nest.Bio Labs. While specific details of his early career are not provided, it is clear his journey has equipped him with a profound understanding of both scientific innovation and venture capital dynamics. His career trajectory likely includes significant roles in venture capital, corporate development, or perhaps even direct scientific research, all contributing to his comprehensive perspective. James is known for his collaborative approach, working closely with founders to navigate challenges and accelerate growth. He champions an entrepreneurial spirit, believing in the power of visionary teams to drive transformative change.
Through his work, James Weis has been pivotal in shaping the trajectory of numerous promising startups within the Nest.Bio ecosystem. While specific investment names are proprietary, his influence is evident in the robust growth and successful milestones achieved by companies under his guidance. He is not merely an investor but a dedicated mentor, offering strategic advice on everything from R&D pipelines to market entry strategies. James's vision aligns perfectly with Nest.Bio Labs' mission to build a healthier future by investing in the most innovative minds and technologies in the life sciences.
James Weis is a Partner at Nest.Bio Labs, a leading organization focused on investing in and developing innovative biotechnology and life sciences companies.
James Weis primarily invests in early-stage biotechnology, life sciences, and healthcare technology companies. His focus areas include advanced therapeutics, diagnostics, medical devices, and digital health solutions.
James Weis works as a Partner at Nest.Bio Labs, an organization dedicated to fostering innovation in the biotech and life sciences sectors.
